OncoNOx ApS

OncoNOx develops innovative, proprietary treatments for human diseases. Using our unique medicinal chemistry approach, we generate de novo or transform already marketed compounds into powerful drugs, which potently inhibit disease pathogenetic pathways in validated animal models resembling human diseases

Read more here - About OncoNOx